Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study

H Wang, Y Wei, CT Hung, G Lin, X Jiang, C Li… - The Lancet Infectious … - thelancet.com
Background Studies have established the short-term efficacy of nirmatrelvir–ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …

Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study

H Wang, Y Wei, CT Hung, G Lin, X Jiang… - The Lancet … - pubmed.ncbi.nlm.nih.gov
Background Studies have established the short-term efficacy of nirmatrelvir-ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …

Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study.

H Wang, Y Wei, CT Hung, G Lin, X Jiang… - The Lancet. Infectious …, 2024 - europepmc.org
Background Studies have established the short-term efficacy of nirmatrelvir-ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …

Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study

H Wang, Y Wei, CT Hung, G Lin, X Jiang, C Li… - The Lancet Infectious …, 2024 - Elsevier
Background Studies have established the short-term efficacy of nirmatrelvir–ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …